TrademarkDir
ARNATAR THERAPEUTICS CURE FOR CAUSE
LIVE

Serial Number

97594202

Owner

Arnatar Therapeutics, Inc.

Attorney

Andrew T. Rissler

Filing Date

Sep 16, 2022

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

ARNATAR THERAPEUTICS CURE FOR CAUSE Trademark

Serial Number: 97594202

ARNATAR THERAPEUTICS CURE FOR CAUSE is a trademark filed by Arnatar Therapeutics, Inc. on September 16, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Arnatar Therapeutics, Inc. (2 trademarks)

10355 Science Center Dr, STE 130
San Diego, CA 92121

Entity Type: 03

Arnatar Therapeutics

10355 Science Center Dr, STE 130
San Diego, CA 92121

Entity Type: 16

Trademark Details

Filing Date

September 16, 2022

Registration Date

Not Registered

Published for Opposition

September 26, 2023

Goods & Services

Medicines, namely, medical preparations for preventing or treating cardiovascular and metabolic diseases, as well as rare genetic diseases

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 28, 2026 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 28, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 28, 2026 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 20, 2026 EXRA
SOU EXTENSION 5 GRANTED
May 20, 2026 EX5G
SOU TEAS EXTENSION RECEIVED
May 19, 2026 EEXT
SOU EXTENSION 5 FILED
May 18, 2026 EXT5
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 20, 2026 EXRA
SOU EXTENSION 4 GRANTED
Jan 20, 2026 EX4G
SOU EXTENSION RECEIVED WITH TEAS PETITION
Jan 16, 2026 TPEX
NOTICE OF REVIVAL - E-MAILED
Jan 16, 2026 NREV
PETITION TO REVIVE-GRANTED
Jan 16, 2026 PETG
TEAS PETITION TO REVIVE RECEIVED
Jan 16, 2026 PROA
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Dec 22, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Dec 22, 2025 ABN6
SOU EXTENSION 4 FILED
Nov 21, 2025 EXT4
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 21, 2025 EXRA
SOU EXTENSION 3 GRANTED
May 21, 2025 EX3G
SOU EXTENSION 3 FILED
May 20, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
May 20, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 3, 2025 EXRA
SOU EXTENSION 2 GRANTED
Jan 3, 2025 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 30, 2024 AITU
SOU EXTENSION 2 FILED
Nov 13, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Nov 13, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 15, 2024 EXRA
SOU EXTENSION 1 GRANTED
May 14, 2024 EX1G
SOU EXTENSION 1 FILED
May 14, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
May 14, 2024 EEXT
CORRECTED NOA E-MAILED
Dec 23, 2023 NOAC
POST PUBLICATION AMENDMENT - ENTERED
Dec 22, 2023 CHPB
ASSIGNED TO PETITION STAFF
Dec 20, 2023 APET
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 21, 2023 NOAM
TEAS POST PUBLICATION AMENDMENT RECEIVED
Nov 16, 2023 EPPA
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 26, 2023 NPUB
PUBLISHED FOR OPPOSITION
Sep 26, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 6, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 17, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 16, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 15, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 15, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 29, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jun 29, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jun 29, 2023 CNRT
ASSIGNED TO EXAMINER
Jun 28, 2023 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Oct 5, 2022 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 4, 2022 NWOS
NEW APPLICATION ENTERED
Sep 20, 2022 NWAP

Related Trademarks

More from this Owner

ARNATAR THERAPEUTICS

ARNATAR THERAPEUTICS

ARNATAR THERAPEUTICS

ARNATAR THERAPEUTICS